Arbutus Biopharma Corp
ABUS | NASDAQ
$5
$0 (0.00%)
Sep 22, 2026, 11:33 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 181.72M | 191.45M | 14.08M | 14.61M | 15.42M | 6.4M | 6.17M | 6.74M | 10.06M | 12.99M | 18.14M | 22.24M | 23.54M | 33.13M | 39.02M | 35.98M | 33.37M | 21.46M | 10.99M | 10.17M | 8.35M | 7.54M |
Cost of Revenue | 33K | 33K | 8.98M | 17.78M | 17.77M | 17.77M | 8.81M | 17.56M | 17.56M | 17.56M | 17.56M | 22.95M | 22.95M | 22.95M | 22.95M | 19.21M | 19.21M | 35.01M | 48.79M | 45.97M | 58.04M | 52.7M |
Gross Profit | 181.69M | 191.41M | 5.1M | -3.17M | -2.35M | -11.37M | -2.64M | -10.82M | -7.5M | -4.58M | 577K | -708K | 586K | 10.18M | 16.07M | 16.77M | 14.16M | -13.56M | -37.81M | -35.81M | -49.69M | -45.17M |
Operating Income | 147.22M | 154.67M | -49.11M | -55.4M | -68.54M | -91.61M | -76.32M | -83.13M | -83.25M | -80.05M | -78.1M | -79.92M | -76.17M | -71.9M | -65.46M | -63.69M | -64.29M | -68.82M | -73.52M | -69.03M | -65.84M | -60.33M |
Interest Income | 3.49M | 3.69M | 4.07M | 4.66M | 5.45M | 6.24M | 6.59M | 6.59M | 6.33M | 5.97M | 5.69M | 5.17M | 4.37M | 3.3M | 2.19M | 1.28M | 612K | 247K | 127K | 193K | 266K | 435K |
Pretax Income | 153.05M | 160.72M | -33.5M | -42.28M | -54.25M | -76.57M | -69.92M | -76.7M | -77.09M | -74.39M | -72.85M | -75.47M | -72.93M | -70.03M | -65.01M | -64.4M | -65.99M | -71.19M | -76.25M | -71.97M | -71.57M | -66.27M |
Net Income | 153.05M | 160.72M | -33.5M | -42.28M | -54.25M | -76.57M | -69.92M | -76.7M | -77.09M | -74.39M | -72.85M | -75.47M | -72.93M | -70.03M | -69.46M | -68.85M | -70.44M | -75.63M | -76.25M | -71.97M | -71.57M | -66.27M |
Selling & General & Admin | 16.48M | 15.94M | 15.89M | 20.63M | 22.13M | 26.35M | 25.83M | 22.5M | 23.8M | 22.24M | 22.48M | 21.62M | 19.27M | 18.49M | 17.83M | 18.18M | 18.87M | 18.15M | 17.14M | 16.2M | 16.08M | 15.17M |
Research & Development | 17.8M | 20.4M | 25.24M | 29.05M | 37.54M | 47.59M | 54.04M | 62.79M | 68.69M | 70.83M | 73.7M | 79.09M | 78.97M | 84.22M | 84.41M | 80.67M | 77.33M | 70.18M | 65.5M | 62.68M | 58.04M | 52.7M |
Other Expenses | 191K | 403K | 13.08M | 2.55M | 6.52M | 6.31M | -6.19M | -12.98M | -16.74M | -17.59M | -17.5M | -21.5M | -21.49M | -20.64M | -20.72M | -18.4M | -17.75M | -33.07M | -46.92M | -45.66M | -57.97M | -52.71M |
Operating Expenses | 34.47M | 36.74M | 54.21M | 52.22M | 66.19M | 80.25M | 73.68M | 72.31M | 75.75M | 75.48M | 78.68M | 79.21M | 76.76M | 82.07M | 81.53M | 80.46M | 78.44M | 55.27M | 35.72M | 33.22M | 16.15M | 15.17M |
Interest Expense | 76K | 86K | 97K | 109K | 115K | 121K | 137K | 151K | 168K | 305K | 459K | 724K | 1.11M | 1.42M | 1.73M | 1.98M | 2.31M | 2.59M | 2.86M | 3.09M | 3.41M | 3.74M |
Selling & Marketing Expenses | n/a | n/a | n/a | -11K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 34.5M | 36.78M | 63.19M | 70M | 83.96M | 98.02M | 82.49M | 89.88M | 93.31M | 93.04M | 96.24M | 102.16M | 99.71M | 105.02M | 104.48M | 99.67M | 97.66M | 90.28M | 84.51M | 79.19M | 74.19M | 67.87M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.44M | 4.44M | 4.44M | 4.44M | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 197.47M | 193.77M | 191.6M | 191.78M | 191.55M | 190.71M | 185.61M | 189M | 188.04M | 175.63M | 168.44M | 167.51M | 166.06M | 161.64M | 154.42M | 151M | 148.75M | 143.32M | 101.29M | 101.02M | 96.87M | 93.43M |
Shares Outstanding (Diluted) | 197.47M | 195.21M | 191.6M | 191.78M | 192.4M | 190.71M | 189.96M | 189M | 188.04M | 175.63M | 168.44M | 167.51M | 166.06M | 161.64M | 154.42M | 151M | 148.75M | 148.43M | 101.29M | 101.29M | 96.87M | 93.43M |
EPS (Basic) | 0.79 | 0.83 | -0.18 | -0.22 | -0.28 | -0.41 | -0.38 | -0.42 | -0.44 | -0.43 | -0.43 | -0.47 | -0.46 | -0.45 | -0.47 | -0.53 | -0.61 | -0.71 | -0.78 | -0.75 | -0.80 | -0.80 |
EPS (Diluted) | 0.78 | 0.82 | -0.18 | -0.22 | -0.28 | -0.41 | -0.38 | -0.42 | -0.44 | -0.43 | -0.43 | -0.47 | -0.46 | -0.45 | -0.47 | -0.53 | -0.61 | -0.71 | -0.78 | -0.75 | -0.80 | -0.80 |
EBITDA | 153.17M | 160.85M | -33.04M | -44.65M | -56.29M | -78.26M | -71.57M | -76.4M | -76.73M | -73.91M | -72.24M | -72.72M | -69.83M | -66.58M | -61.19M | -60.72M | -61.87M | -66.06M | -70.74M | -66.25M | -65.5M | -60.47M |
EBIT | 153.13M | 160.81M | -33.4M | -45.33M | -57.3M | -79.62M | -72.95M | -77.8M | -78.17M | -75.33M | -73.64M | -74.08M | -71.16M | -67.94M | -62.62M | -62.27M | -63.52M | -67.76M | -72.49M | -68.07M | -67.35M | -62.39M |
Depreciation & Amortization | 44K | 44K | 366K | 688K | 1.01M | 1.36M | 1.38M | 1.41M | 1.44M | 1.43M | 1.4M | 1.35M | 1.33M | 1.37M | 1.43M | 1.55M | 1.65M | 1.7M | 1.75M | 1.81M | 1.86M | 1.92M |
Add to Watchlist
Select watchlists to add or remove ABUS